Clinical Trials Browser

INDUSTRY × BCG Vaccine × Genitourinary × Clear all

NCT04165317 2026-01-22

CREST

Phase 3 Active not recruiting

1,068 enrolled 20 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03528694 2025-11-25

POTOMAC

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05981131 2025-03-13

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05037279 2025-02-20

EVER

Phase 3 Recruiting

Urinary Bladder Neoplasms, Recurrence

NCT02792192 2021-10-28

Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants

Phase 1/2 Terminated

24 enrolled 18 charts

Urinary Bladder Neoplasms

NCT00694915 2021-08-17

STCC

Phase 2 Completed

Urinary Bladder Neoplasms

NCT02010203 2020-02-17

A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Phase 1/2 Terminated

104 enrolled 21 charts

Urinary Bladder Neoplasms, Neoplasms

NCT01284205 2014-08-29

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Phase 3 Withdrawn

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00514072 2012-08-09

Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms